Glucagon-like peptide-1 receptor agonists, an increasingly popular class of weight loss medications, have been found to be associated with new onset acne in women, according to a research letter published in Journal of the American Academy of Dermatology
If you're considering adding it to your stack, this guide breaks down what the research suggests about dosing, timing, and how to use it safely
The different mechanisms mean different side effect timelines and patterns
Early changes often occur internally before they are visible on the scale
Chemistry of Materials 28 , 40094016, (2016)
We also help patients whose insurance does not cover GLP-1 medications for weight loss connect with manufacturer savings programs that can reduce costs substantially